• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    20 Years: A Discussion on the Past & Future of Medical Product Outsourcing

    A Combined Effort for Drug Delivery & Combo Product Technology

    Examining Medical Packaging & Sterilization on Multiple Fronts

    Medical Molding Modernized

    Computer Concepts for Medical Device Design
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Teleflex’s Wattson temporary pacing guidewire FDA cleared

    PDC Partners with David Schnur Associates to Provide Manufacturing Solutions

    Olympus Releases Next-Gen ESG-410 Electrosurgical Generator

    NICO Corporation Touts Positive ENRICH Trial Results

    Study Reveals Graphene-Based Biosensors' Potential in Detecting Critical Biomarker
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    20 Years: A Discussion on the Past & Future of Medical Product Outsourcing

    A Combined Effort for Drug Delivery & Combo Product Technology

    Examining Medical Packaging & Sterilization on Multiple Fronts

    Medical Molding Modernized

    Computer Concepts for Medical Device Design
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Elizabeth Holmes’ Pre-Prison Public Persona

    Trending in Healthcare Dealmaking: Creativity, Diversification, and Distress

    How Human Factors Engineering Can Contribute to Medical Device Packaging

    How Companies Can Create a Unique Selling Proposition

    Updating Medical Device Software in the Field
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    LEMO USA Inc.

    NDH Medical Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies

    Halkey-Roberts Corporation
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How the CHIPS Act and R&D Tax Credits Will Shape the Medtech Manufacturing Landscape

    Solving the Skills Gap Stalling the March of UK Life Sciences

    5 Ways to Reduce Nearshoring & Reshoring Costs Using Automation

    The Future of Hearing Aids: xMEMS Develops All-Silicon, Solid-State Micro Speaker

    Navigating Chinese Regulatory Requirements for Medical Device Localization
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    LEMO USA Inc.

    NDH Medical Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies

    Halkey-Roberts Corporation
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    The Heart of the Matter: Trends in Cardiology

    Of the three major segments of coronary stents, bioabsorbable stents are expected to have the highest growth between now and 2022.

    Maria Shepherd, President and Founder, Medi-Vantage11.04.20
    When the first reports were issued about paclitaxel, many were concerned about paclitaxel coated stents and possible increased mortality in patients treated with paclitaxel-coated stents/balloons for peripheral artery disease.1 The authors of a JACC article cite multiple meta-analyses as do those who argue against the use of paclitaxel coated devices, but the real question is, what impact does this have on interventional cardiology devices?

    In 1993, the FDA approved the first coronary intervention stent in the U.S., Cook Medical’s Gianturco-Roubin Flex Stent bare-metal stent (BMS). Approval of the Flex-Stent came one year after a review by FDA’s circulatory system devices panel.2

    Cook launched its coronary stent with great fanfare using company-sponsored training sessions beginning in July 1993 and priced it at $1,150.2 Interventional cardiologists (IC) were enthusiastic about the potential for the stent technology to treat coronary artery disease and lined up for training to treat their patients. The stent was also marketed in Korea, Australia, and Singapore.

    With such an enormous lead, how did Cook lose first-mover advantage in a market that would grow to more than $7 billion in global sales? The coronary stent market is forecasted to grow from $7.16 billion in 2016 and reach $10.3 billion by 2021 (Table 1) with an astonishing CAGR of 7.6 percent in a market almost 30 years old.3


    Table 1: Global stent market growth3

    Why Is It Important?
    At the time, before the market direction was clear, game changing product design decisions like “Which drug coating do we use on our first DES?” are incredibly tough calls to make—significant dollars and market position are at risk.

    It began with the introduction of higher cost drug-eluting stents (DES) that caused a significant shift in the revenues of the stent market. DES were first sold in the U.S. in 2002, a daring strategic move with higher business risk to cardiovascular device companies, but it also offered the upside of delivering the holy grail—a lower restenosis rate. Choosing the drug to use to coat the BMS was a complex decision for companies. Many pharmaceutical compounds were evaluated, including Taxol (paclitaxel), which was also used as an anti-cancer medication. It was argued paclitaxel was a risk to patient safety because the dosage range over which paclitaxel is used in stenting is close to the drug’s toxicity level.4

    Cordis (then a division of Johnson & Johnson; now part of Cardinal Health) chose Sirolimus in its DES and began an exclusive licensing agreement with Wyeth Pharmaceuticals. Cordis chose Sirolimus because it could inhibit cellular growth linked to restenosis, could be formulated into a polymer matrix, and was highly stable. Sirolimus is effective over a wide range of concentrations and, in evaluations, was non-toxic at high concentrations. The Cordis Cypher was the first mover in the DES market.

    By 2003, the Cypher penetrated the BMS market by more than 60 percent. Cordis had many competitors—Boston Scientific, Guidant, and Medtronic—all working on DES offerings. In 2004, Boston Scientific was awarded FDA approval for its Taxus DES.

    Newcomers to this competitive market know clinical data is a must have, and industry relationships are hard to displace. Almost all ICs take charge in the interventional suite and medical device representatives have their work cut out for them to be subtly central to the procedure to generate and maintain influence, while bringing service to the IC that cultivates loyalty to the products, the sales person, and the company.5 Medtech representatives and some doctors think a sales rep brings many benefits to the hospital, by amplifying productivity and offsetting deficits of procedure room staff.

    Where Is This Growth Coming From?
    Of the three major segments of coronary stents—BMS, DES, and bioabsorbable stents—bioabsorbable stents are expected to have the highest growth between now and 2022,6 although they represent the smallest revenue segment of the group. The worldwide bioabsorbable stent market is forecast to reach $417 million by 2022, up from $242 million in 2017 (Table 2)—a CAGR of 11.5 percent.6 Market drivers of bioresorbable stents are the growing aging population, rising percutaneous coronary intervention procedures, and increasing demand created by medical device manufacturers’ clinical trials of bioresorbable stents. There are highly regarded clinical benefits attributed to bioresorbable stents, such as a decrease in thrombosis and inflammation complications.7 One market obstacle was the high cost of bioabsorbable coronary stents when the Absorb stent from Abbott was introduced in 2016.


    Table 2: Global bioabsorbable stent market revenue forecast6

    Shifting the ASP Up, Up, Up
    It doesn’t happen very often, but when introduced, the innovation and promise of bioabsorbable coronary stents caused an ASP shift in the upwards direction. ASP data is difficult to obtain and a 2019 article about the sales of coronary stents in India provide insights to global pricing and the power of enormous market demand in a country with a population of more than 1.4 billion people.

    In February 2017, the government of India regulated the selling price of coronary stents. According to an interventional cardiologist in India, stent prices dropped by an average of 80 percent.8

    Before the price was regulated, the cost to the patient of the only approved bioresorbable stent in India was 200,000 Indian Rupees (INR; approximately $2,800), compared to DES costs that ranged from INR 85,000 to 160,000 ($1,190 to $2,240). Allegations were made that hospitals and ICs obtained kickbacks for implanting stents.8

    The Indian government cut and regulated stent prices significantly (Table 3). The cost for patients for a bioabsorbable stent was stabilized to INR 60,000 (approximately $840). BMS and DES were capped at INR 7,500 and 30,000, respectively ($105 and $420).8 The government reportedly used industry-supplied data while Indian physicians voiced concerns about how low profitability would drive away large stent manufacturers from supplying the newest technologies. The medical device industry pushed back, stating that supplying cardiology products at a loss would cause them to lose money, obviously to put pressure on the government. In early 2017, Abbott announced it would withdraw two stents from the Indian market after the government’s move to cap stent prices.9 The Abbott bioresorbable stent disappeared from shelves.


    Table 3: Changes to stent prices in India (2017)8

    The Medi-Vantage Perspective
    By 2020, DES continued to dominate the overall coronary stent market and had the highest revenue market share forecasted until the end of 2024, estimated at nearly 95 percent of the total market.10 Good marketing and an intimate knowledge of pricing strategy was central to managing this enormous global market. Make price strategy a key part of your marketing and product development so the market you manage gets all the investment in development it warrants at your medical device company. 

    References
    1. bit.ly/mpo201101
    2. bit.ly/mpo201102
    3. bit.ly/mpo201103
    4. bit.ly/mpo201104
    5. bit.ly/mpo201105
    6. bit.ly/mpo201106
    7. bit.ly/mpo201107
    8. bit.ly/mpo201108
    9. bit.ly/mpo201109
    10. bit.ly/mpo201110


    Maria Shepherd has more than 20 years of leadership experience in medical device/life-science marketing in small startups and top-tier companies. After her industry career, including her role as VP of marketing for Oridion Medical where she boosted the company valuation prior to its acquisition by Medtronic, and director of marketing for Philips Medical, she founded Medi-Vantage. Medi-Vantage provides marketing and business strategy and innovation research for the medical device industry. Shepherd has taught marketing and product development courses, speaks regularly at medtech conferences, and can be reached at mshepherd@medi-vantage. Visit her website at www.medi-vantage.com.
    Related Searches
    • Cardiovascular
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    Providien Providien
    Beaumont Beaumont
    Zeus Zeus
    Medi-Vantage Medi-Vantage
    Nissha Medical Technologies Nissha Medical Technologies
    JK Medirise-Disposable Medical Device Company JK Medirise-Disposable Medical Device Company
    DDL Inc. DDL Inc.
    sfm medical devices GmbH sfm medical devices GmbH
    Simbex Simbex
    Simplexity Product Development Inc. Simplexity Product Development Inc.
    BMP Medical - Delivering Custom Plastics Manufactured Solutions BMP Medical - Delivering Custom Plastics Manufactured Solutions
    High Tech Turning Co. Inc. High Tech Turning Co. Inc.
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Accu-Tube Appoints Matthew Haddle as CEO Accu-Tube Appoints Matthew Haddle as CEO

    Related Buyers Guide Companies

    • Providien

      Providien

      ...
      Bonalyn Boyd, Marketing Manager 11.30.22

    • Beaumont

      Beaumont

      ...
      Eliana Pietras, Marketing Communications Lead 11.30.22

    • Zeus

      Zeus

      ...
      Laura Bright, Ad Manager 11.18.22


    • Medi-Vantage

      ...
      Maria Shepherd 11.18.22

    • Nissha Medical Technologies

      ...
      Amy Jeary, Market Development Manager 11.18.22

    Loading, Please Wait..

    Trending
    • Olympus To Establish Digital Excellence Centers
    • A New Approach To Post-Market Surveillance
    • Philips Names New Supervisory Board Chairman
    • Healthcare Changes Prompt Medtronic To Merge Sales Force Medtronic, Inc. Is Combining Its U.S. Ca
    • Labcorp's Clinical Development Spinoff To Be Called Fortrea
    Breaking News
    • Teleflex’s Wattson temporary pacing guidewire FDA cleared
    • PDC Partners with David Schnur Associates to Provide Manufacturing Solutions
    • Olympus Releases Next-Gen ESG-410 Electrosurgical Generator
    • NICO Corporation Touts Positive ENRICH Trial Results
    • Study Reveals Graphene-Based Biosensors' Potential in Detecting Critical Biomarker
    View Breaking News >
    CURRENT ISSUE

    June 2023

    • 20 Years: A Discussion on the Past & Future of Medical Product Outsourcing
    • A Combined Effort for Drug Delivery & Combo Product Technology
    • Examining Medical Packaging & Sterilization on Multiple Fronts
    • Medical Molding Modernized
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Blue Diamond, Brightseed Partner To Discover New Almond Bioactives
    GOED Publishes Report on EPA and DHA’s Impact on Brain Health
    Alkemist Labs Creates Validated Method for Plant and Fungi-Based Psychedelics
    Coatings World

    Latest Breaking News From Coatings World

    Sandrine Garnier Joins ChemQuest as a Director
    Greenbuild Announces 2023 Keynote Speaker
    PPG’s New Paint for a New Start Initiative to Beautify Schools Worldwide with Colorful Makeovers
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    PDC Partners with David Schnur Associates to Provide Manufacturing Solutions
    Olympus Releases Next-Gen ESG-410 Electrosurgical Generator
    NICO Corporation Touts Positive ENRICH Trial Results
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Qosina, Carolina Components Partner to Market Bioprocess Components
    Astellas, KateTx Enter Exclusive License Agreement to Develop KT430
    Telix Opens $21.2M European Radiopharmaceutical Production Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Boots CFO Michael Snape Resigns
    Beiersdorf Shares Progress of Its Sustainability Agenda
    Estée Lauder Announces Second Edition of Beauty&You Brand Incubator Program
    Happi

    Latest Breaking News From Happi

    Covey Skincare Names New CEO
    TerraCycle and Wrinkles Schminkles Partner in new Recycling Program
    FDA Sends Warning Letter To Maker of Mr. Lulu Sunscreen Drops
    Ink World

    Latest Breaking News From Ink World

    SICPA Inaugurates Its unlimitrust Campus
    Siegwerk’s Center of Excellence in France Receives Facelift
    Epson announces MakeTheSwitch Campaign
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Gallus to celebrate 100 years, opening new Gallus Experience Center
    Mark Andy holds successful Low Migration Workshop
    Ryback & Ryback Consulting launches Machinery division
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Terra Baby Diapers, Wipes Launch in U.S. and Canada
    The Honest Company to Exit Europe, Asia
    TechnoPlants to Exhibit at ITMA
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Osso VR Launches Virtual Reality Training Program
    Catalyst OrthoScience Names Mark Quick as CFO
    European Regulators Approve Amber Implants' VCFix Spinal System Study
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Sensormatic Unveils Sensormatic Synergy Media Display
    ams OSRAM Receives the German Innovation Award
    ASSA ABLOY Receives Clearance from Mexico for HHI Acquisition

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login